vs
安进（AMGN）与PILGRIMS PRIDE CORP（PPC）财务数据对比。点击上方公司名可切换其他公司
安进的季度营收约是PILGRIMS PRIDE CORP的1.9倍（$8.6B vs $4.5B），安进净利率更高（21.1% vs 2.2%，领先18.9%），安进同比增速更快（5.8% vs 1.6%），过去两年安进的营收复合增速更高（1.4% vs -0.3%）
安进是总部位于美国加利福尼亚州千橡市的跨国生物制药企业，公司名称取自最初的全称「应用分子遗传学」的缩写组合，按营收规模排名位列全球生物医药企业第18位，专注于研发、生产及商业化创新生物药物，为全球患者提供优质治疗选择。
Pilgrim's Pride是美国跨国食品企业，为美国及波多黎各最大的鸡肉生产商之一，同时是墨西哥第二大鸡肉生产商。公司2009年12月脱离破产状态，2011年将美国总部迁至科罗拉多州格里利，由JBS集团控股，2016年11月底以3.5亿美元收购Gold'n Plump。
AMGN vs PPC — 直观对比
营收规模更大
AMGN
是对方的1.9倍
$4.5B
营收增速更快
AMGN
高出4.2%
1.6%
净利率更高
AMGN
高出18.9%
2.2%
两年增速更快
AMGN
近两年复合增速
-0.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $8.6B | $4.5B |
| 净利润 | $1.8B | $101.5M |
| 毛利率 | 68.2% | 7.6% |
| 营业利润率 | 30.9% | 3.6% |
| 净利率 | 21.1% | 2.2% |
| 营收同比 | 5.8% | 1.6% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $3.34 | $0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMGNPPC
| Q1 26 | $8.6B | $4.5B | ||
| Q4 25 | $9.9B | $4.5B | ||
| Q3 25 | $9.6B | $4.8B | ||
| Q2 25 | $9.2B | $4.8B | ||
| Q1 25 | $8.1B | $4.5B | ||
| Q4 24 | $9.1B | $4.4B | ||
| Q3 24 | $8.5B | $4.6B | ||
| Q2 24 | $8.4B | $4.6B |
净利润AMGNPPC
| Q1 26 | $1.8B | $101.5M | ||
| Q4 25 | $1.3B | $88.0M | ||
| Q3 25 | $3.2B | $342.8M | ||
| Q2 25 | $1.4B | $355.5M | ||
| Q1 25 | $1.7B | $296.0M | ||
| Q4 24 | $627.0M | $235.9M | ||
| Q3 24 | $2.8B | $349.9M | ||
| Q2 24 | $746.0M | $326.3M |
毛利率AMGNPPC
| Q1 26 | 68.2% | 7.6% | ||
| Q4 25 | 69.8% | 9.5% | ||
| Q3 25 | 67.8% | 13.9% | ||
| Q2 25 | 67.2% | 15.0% | ||
| Q1 25 | 63.6% | 12.4% | ||
| Q4 24 | 65.7% | 12.7% | ||
| Q3 24 | 61.1% | 14.9% | ||
| Q2 24 | 61.4% | 15.2% |
营业利润率AMGNPPC
| Q1 26 | 30.9% | 3.6% | ||
| Q4 25 | 27.6% | 4.5% | ||
| Q3 25 | 26.4% | 10.4% | ||
| Q2 25 | 28.9% | 10.8% | ||
| Q1 25 | 14.5% | 9.1% | ||
| Q4 24 | 25.4% | 7.0% | ||
| Q3 24 | 24.1% | 11.1% | ||
| Q2 24 | 22.8% | 9.7% |
净利率AMGNPPC
| Q1 26 | 21.1% | 2.2% | ||
| Q4 25 | 13.5% | 1.9% | ||
| Q3 25 | 33.7% | 7.2% | ||
| Q2 25 | 15.6% | 7.5% | ||
| Q1 25 | 21.2% | 6.6% | ||
| Q4 24 | 6.9% | 5.4% | ||
| Q3 24 | 33.3% | 7.6% | ||
| Q2 24 | 8.9% | 7.2% |
每股收益（稀释后）AMGNPPC
| Q1 26 | $3.34 | $0.43 | ||
| Q4 25 | $2.45 | $0.37 | ||
| Q3 25 | $5.93 | $1.44 | ||
| Q2 25 | $2.65 | $1.49 | ||
| Q1 25 | $3.20 | $1.24 | ||
| Q4 24 | $1.17 | $1.00 | ||
| Q3 24 | $5.22 | $1.47 | ||
| Q2 24 | $1.38 | $1.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.0M | $542.4M |
| 总债务越低越好 | $57.3B | $3.1B |
| 股东权益账面价值 | $9.2B | $3.7B |
| 总资产 | $92.5B | $10.2B |
| 负债/权益比越低杠杆越低 | 6.24× | 0.83× |
8季度趋势，按日历期对齐
现金及短期投资AMGNPPC
| Q1 26 | $12.0M | $542.4M | ||
| Q4 25 | $9.1B | $640.2M | ||
| Q3 25 | $9.4B | $612.6M | ||
| Q2 25 | $8.0B | $849.0M | ||
| Q1 25 | $8.8B | $2.1B | ||
| Q4 24 | $12.0B | $2.0B | ||
| Q3 24 | $9.0B | $1.9B | ||
| Q2 24 | $9.3B | $1.3B |
总债务AMGNPPC
| Q1 26 | $57.3B | $3.1B | ||
| Q4 25 | $54.6B | $3.1B | ||
| Q3 25 | $54.6B | $3.1B | ||
| Q2 25 | $56.2B | $3.1B | ||
| Q1 25 | $57.4B | $3.2B | ||
| Q4 24 | $60.1B | $3.2B | ||
| Q3 24 | $60.4B | $3.2B | ||
| Q2 24 | $62.6B | $3.2B |
股东权益AMGNPPC
| Q1 26 | $9.2B | $3.7B | ||
| Q4 25 | $8.7B | $3.7B | ||
| Q3 25 | $9.6B | $3.5B | ||
| Q2 25 | $7.4B | $3.7B | ||
| Q1 25 | $6.2B | $3.1B | ||
| Q4 24 | $5.9B | $4.2B | ||
| Q3 24 | $7.5B | $4.2B | ||
| Q2 24 | $5.9B | $3.7B |
总资产AMGNPPC
| Q1 26 | $92.5B | $10.2B | ||
| Q4 25 | $90.6B | $10.3B | ||
| Q3 25 | $90.1B | $10.0B | ||
| Q2 25 | $87.9B | $10.1B | ||
| Q1 25 | $89.4B | $11.0B | ||
| Q4 24 | $91.8B | $10.7B | ||
| Q3 24 | $90.9B | $10.7B | ||
| Q2 24 | $90.9B | $10.1B |
负债/权益比AMGNPPC
| Q1 26 | 6.24× | 0.83× | ||
| Q4 25 | 6.31× | 0.84× | ||
| Q3 25 | 5.67× | 0.87× | ||
| Q2 25 | 7.57× | 0.83× | ||
| Q1 25 | 9.24× | 1.02× | ||
| Q4 24 | 10.23× | 0.76× | ||
| Q3 24 | 8.02× | 0.76× | ||
| Q2 24 | 10.57× | 0.85× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.2B | — |
| 自由现金流经营现金流 - 资本支出 | $1.5M | — |
| 自由现金流率自由现金流/营收 | 0.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 1.20× | — |
| 过去12个月自由现金流最近4个季度 | $7.1B | — |
8季度趋势，按日历期对齐
经营现金流AMGNPPC
| Q1 26 | $2.2B | — | ||
| Q4 25 | $1.6B | $291.2M | ||
| Q3 25 | $4.7B | $458.3M | ||
| Q2 25 | $2.3B | $495.2M | ||
| Q1 25 | $1.4B | $126.9M | ||
| Q4 24 | $4.8B | $349.3M | ||
| Q3 24 | $3.6B | $651.1M | ||
| Q2 24 | $2.5B | $718.6M |
自由现金流AMGNPPC
| Q1 26 | $1.5M | — | ||
| Q4 25 | $961.0M | $10.0M | ||
| Q3 25 | $4.2B | $275.9M | ||
| Q2 25 | $1.9B | $339.1M | ||
| Q1 25 | $980.0M | $28.1M | ||
| Q4 24 | $4.4B | $176.6M | ||
| Q3 24 | $3.3B | $565.3M | ||
| Q2 24 | $2.2B | $617.7M |
自由现金流率AMGNPPC
| Q1 26 | 0.0% | — | ||
| Q4 25 | 9.7% | 0.2% | ||
| Q3 25 | 44.4% | 5.8% | ||
| Q2 25 | 20.8% | 7.1% | ||
| Q1 25 | 12.0% | 0.6% | ||
| Q4 24 | 48.4% | 4.0% | ||
| Q3 24 | 39.0% | 12.3% | ||
| Q2 24 | 26.5% | 13.5% |
资本支出强度AMGNPPC
| Q1 26 | 0.0% | — | ||
| Q4 25 | 6.5% | 6.2% | ||
| Q3 25 | 4.6% | 3.8% | ||
| Q2 25 | 4.0% | 3.3% | ||
| Q1 25 | 5.0% | 2.2% | ||
| Q4 24 | 4.1% | 4.0% | ||
| Q3 24 | 3.0% | 1.9% | ||
| Q2 24 | 2.8% | 2.2% |
现金转化率AMGNPPC
| Q1 26 | 1.20× | — | ||
| Q4 25 | 1.20× | 3.31× | ||
| Q3 25 | 1.46× | 1.34× | ||
| Q2 25 | 1.59× | 1.39× | ||
| Q1 25 | 0.80× | 0.43× | ||
| Q4 24 | 7.61× | 1.48× | ||
| Q3 24 | 1.26× | 1.86× | ||
| Q2 24 | 3.30× | 2.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMGN
| Product sales | $8.2B | 95% |
| Other revenues | $400.0M | 5% |
PPC
| U.S | $2.6B | 58% |
| Europe | $1.4B | 30% |
| Mexico | $545.5M | 12% |
